20: LRRK2 ACTIVITY MODULATES PANETH CELL FUNCTION IN CROHN'S DISEASE
Justin L. Kern(Washington University in St. Louis), Ta‐Chiang Liu(Washington University in St. Louis), Annie Arguello(Denali Therapeutics (United States)), Anketse Debebe(Icahn School of Medicine at Mount Sinai), Dermot McGovern(Salford Royal NHS Foundation Trust), Javier De Vicente, Inga Peter(Icahn School of Medicine at Mount Sinai), Thaddeus S. Stappenbeck(Cleveland Clinic), Anthony A. Estrada, Anastasia G. Henry(Denali Therapeutics (United States)), Atika Malique(Saint Louis University), Xiang Wang, Talin Haritunians(Cedars-Sinai Medical Center), Hoang Nguyen(Hudson Institute of Medical Research), Samuel Ballentine(Washington University in St. Louis)
Cited by 0
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
|Cell|2016|2.9k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k